Official Publication of Houston Methodist DeBakey Heart & Vascular Center
IN THIS ISSUE
Guest Editors Steven Petak and Archana Sadhu Guide Issue on Diabetes and the Heart
See MoreCardiac Autonomic Neuropathy in Diabetes Mellitus
Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure
Imaging to Stratify Coronary Artery Disease Risk in Asymptomatic Patients with Diabetes
Update on Management of Type 2 Diabetes for Cardiologists
New Therapeutic Strategies for Type 2 Diabetes
Prediabetes: Why Should We Care?
Central Venous Pathologies: Treatments and Economic Impact
Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology
Loperamide Mimicking Brugada Pattern
Reversed Pulsus Paradoxus in Right Ventricular Failure
Mycobacterium Chimaera Mimicking Sarcoidosis
Immune Checkpoint Inhibitor Related Cardiotoxicity
A Right Ventricular Mass
Letter to the Editor in response to “Role of Subcutaneous Leadless Implantable Cardioverter Defibrillator in Young Patients
Vol 14, Issue 4 (2019)
Showing results for keyword “ SGLT2 inhibitors”
Patricia Mejia Osuna Vol 14, Issue 4
Keywords: heart failure , type 2 diabetes , therapeutic options , DPP-4 inhibitors , GLP-1 agonists , SGLT2 inhibitorsOsuna PM, Brown SJ, Tabatabai LS, Hamilton DJ. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure. Methodist DeBakey Cardiovasc J. 2018;14(4):257-65.
